Ledger.Open graph →

SEC Form D · filed October 10, 2025

Jaguar Health, Inc

Offering

$1.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Steven King · San Francisco, CAExec Jonathan Siegel · San Francisco, CADirector John Micek Iii · San Francisco, CADirector James Bochnowski · San Francisco, CADirector Anula Jayasuriya · San Francisco, CADirector Pravin Chaturvedi · San Francisco, CAExec Jonathan Wolin · San Francisco, CAExec Lisa Conte · San Francisco, CAExec · Director Carol Lizak · San Francisco, CAExec Steven King · San Francisco, CAExec Lisa Conte · San Francisco, CAExec · Director Jonathan Wolin · San Francisco, CAExec John Micek Iii · San Francisco, CADirector Anula Jayasuriya · San Francisco, CADirector Carol Lizak · San Francisco, CAExec James Bochnowski · San Francisco, CADirector Jonathan Siegel · San Francisco, CADirector Pravin Chaturvedi · San Francisco, CAExec Alan Okagaki · Seattle, WAExec Norma Hernandez · Seattle, WAExec Aman Jeloka · Seattle, WADirector Sue Taoka · Seattle, WAExec · Director Mary Houghton · Seattle, WADirector Lee Winslett · Seattle, WADirector Gregory Bradley · Seattle, WAExec Kelly Dulong · Seattle, WADirector Bruce Brooks · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗